• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Simultaneous colonisation of Helicobacter pylori with and without mutations in the 23S rRNA gene in patients with no history of clarithromycin exposure.在无克拉霉素暴露史的患者中,同时存在23S rRNA基因有突变和无突变的幽门螺杆菌定植。
Gut. 1999 Oct;45(4):503-7. doi: 10.1136/gut.45.4.503.
2
Clarithromycin-resistance and point mutations in the 23S rRNA gene in Helicobacter pylori isolates from Japan.日本幽门螺杆菌分离株中23S rRNA基因的克拉霉素耐药性及点突变
J Gastroenterol Hepatol. 2000 Aug;15(8):906-9. doi: 10.1046/j.1440-1746.2000.02072.x.
3
Evaluation of rapid molecular methods for detection of clarithromycin resistance in Helicobacter pylori.用于检测幽门螺杆菌对克拉霉素耐药性的快速分子方法的评估
Eur J Clin Microbiol Infect Dis. 1997 Feb;16(2):162-4. doi: 10.1007/BF01709478.
4
Novel genotypes in Helicobacter pylori involving domain V of the 23S rRNA gene.幽门螺杆菌中涉及23S rRNA基因第五结构域的新型基因型。
Helicobacter. 2007 Oct;12(5):505-9. doi: 10.1111/j.1523-5378.2007.00506.x.
5
Mutations affecting domain V of the 23S rRNA gene in Helicobacter pylori from Cairo, Egypt.埃及开罗幽门螺杆菌23S rRNA基因V结构域的突变
J Chemother. 2016 Oct;28(5):367-70. doi: 10.1179/1973947815Y.0000000067. Epub 2016 Jun 28.
6
PCR using 3'-mismatched primers to detect A2142C mutation in 23S rRNA conferring resistance to clarithromycin in Helicobacter pylori clinical isolates.使用3'-错配引物的聚合酶链反应检测幽门螺杆菌临床分离株中23S rRNA赋予对克拉霉素耐药性的A2142C突变。
J Clin Microbiol. 2000 Feb;38(2):923-5. doi: 10.1128/JCM.38.2.923-925.2000.
7
Characterisation of point mutations in domain V of the 23S rRNA gene of clinical Helicobacter pylori strains and clarithromycin-resistant phenotype in central Vietnam.中越地区临床幽门螺杆菌分离株 23S rRNA 基因 V 区点突变特征及其克拉霉素耐药表型分析。
J Glob Antimicrob Resist. 2019 Mar;16:87-91. doi: 10.1016/j.jgar.2018.09.012. Epub 2018 Sep 25.
8
Cloning and sequence analysis of two copies of a 23S rRNA gene from Helicobacter pylori and association of clarithromycin resistance with 23S rRNA mutations.幽门螺杆菌23S rRNA基因两个拷贝的克隆与序列分析以及克拉霉素耐药性与23S rRNA突变的关联
Antimicrob Agents Chemother. 1997 Dec;41(12):2621-8. doi: 10.1128/AAC.41.12.2621.
9
Accurate prediction of macrolide resistance in Helicobacter pylori by a PCR line probe assay for detection of mutations in the 23S rRNA gene: multicenter validation study.通过用于检测23S rRNA基因突变的PCR线探针检测法准确预测幽门螺杆菌对大环内酯类药物的耐药性:多中心验证研究
Antimicrob Agents Chemother. 2001 May;45(5):1500-4. doi: 10.1128/AAC.45.5.1500-1504.2001.
10
Rapid detection of mutations in the 23S rRNA gene of Helicobacter pylori that confers resistance to clarithromycin treatment to the bacterium.快速检测幽门螺杆菌23S rRNA基因中的突变,这些突变使该细菌对克拉霉素治疗产生耐药性。
J Clin Microbiol. 2001 Feb;39(2):691-5. doi: 10.1128/JCM.39.2.691-695.2001.

引用本文的文献

1
Rifabutin for the Treatment of Infection: A Review.利福布汀用于感染治疗的综述
Pathogens. 2020 Dec 28;10(1):15. doi: 10.3390/pathogens10010015.
2
Analysis of Helicobacter pylori genotypes in clinical gastric wash samples.临床胃冲洗样本中幽门螺杆菌基因型分析
Tumour Biol. 2016 Aug;37(8):10123-32. doi: 10.1007/s13277-016-4886-4. Epub 2016 Jan 29.
3
Clarithromycin-based standard triple therapy can still be effective for Helicobacter pylori eradication in some parts of the Korea.在韩国的某些地区,基于克拉霉素的标准三联疗法对根除幽门螺杆菌仍可能有效。
J Korean Med Sci. 2014 Sep;29(9):1240-6. doi: 10.3346/jkms.2014.29.9.1240. Epub 2014 Sep 2.
4
Molecular Detection of Antibiotic Resistance in South African Isolates of Helicobacter pylori.南非幽门螺杆菌分离株的抗生素耐药性的分子检测。
Gastroenterol Res Pract. 2013;2013:259457. doi: 10.1155/2013/259457. Epub 2013 Apr 24.
5
Characterisation of the genes encoding resistance to metronidazole (rdxA and frxA) and clarithromycin (the 23S-rRNA genes) in South African isolates of Helicobacter pylori.对南非幽门螺杆菌分离株中编码对甲硝唑(rdxA 和 frxA)及克拉霉素(23S - rRNA 基因)耐药性的基因进行鉴定。
Ann Trop Med Parasitol. 2011 Apr;105(3):251-9. doi: 10.1179/136485911X12899838683485.
6
Characterization of clarithromycin resistance in Malaysian isolates of Helicobacter pylori.马来西亚幽门螺杆菌分离株中克拉霉素耐药性的特征分析
World J Gastroenterol. 2009 Jul 7;15(25):3161-5. doi: 10.3748/wjg.15.3161.
7
T2182C mutation is not associated with clarithromycin resistance in Helicobacter pylori.T2182C突变与幽门螺杆菌对克拉霉素的耐药性无关。
Antimicrob Agents Chemother. 2005 Feb;49(2):868; author reply 868-70. doi: 10.1128/AAC.49.2.868-870.2005.
8
Distribution of antibiotic MICs for Helicobacter pylori strains over a 16-year period in patients from Seoul, South Korea.韩国首尔患者幽门螺杆菌菌株16年间抗生素最低抑菌浓度的分布情况。
Antimicrob Agents Chemother. 2004 Dec;48(12):4843-7. doi: 10.1128/AAC.48.12.4843-4847.2004.
9
Basis for the management of drug-resistant Helicobacter pylori infection.耐药幽门螺杆菌感染的管理依据。
Drugs. 2004;64(17):1893-904. doi: 10.2165/00003495-200464170-00003.
10
Molecular testing for antibiotic resistance in Helicobacter pylori.幽门螺杆菌抗生素耐药性的分子检测
Gut. 2002 Mar;50(3):285-9. doi: 10.1136/gut.50.3.285.

本文引用的文献

1
Identification of a 23S rRNA gene mutation in clarithromycin-resistant Helicobacter pylori.耐克拉霉素幽门螺杆菌中23S rRNA基因突变的鉴定
Helicobacter. 1996 Dec;1(4):227-8. doi: 10.1111/j.1523-5378.1996.tb00043.x.
2
Macrolide resistance in Helicobacter pylori: rapid detection of point mutations and assays of macrolide binding to ribosomes.幽门螺杆菌对大环内酯类药物的耐药性:点突变的快速检测及大环内酯类药物与核糖体结合的测定
Antimicrob Agents Chemother. 1997 Dec;41(12):2724-8. doi: 10.1128/AAC.41.12.2724.
3
Macrolide resistance in Helicobacter pylori: mechanism and stability in strains from clarithromycin-treated patients.幽门螺杆菌对大环内酯类药物的耐药性:来自克拉霉素治疗患者菌株的机制与稳定性
Antimicrob Agents Chemother. 1997 Nov;41(11):2550-3. doi: 10.1128/AAC.41.11.2550.
4
Estimates of Helicobacter pylori densities in the gastric mucus layer by PCR, histologic examination, and CLOtest.通过聚合酶链反应(PCR)、组织学检查和尿素酶试验对胃黏液层中幽门螺杆菌密度的估计。
Am J Clin Pathol. 1997 Sep;108(3):284-8. doi: 10.1093/ajcp/108.3.284.
5
The complete genome sequence of the gastric pathogen Helicobacter pylori.胃病原体幽门螺杆菌的全基因组序列。
Nature. 1997 Aug 7;388(6642):539-47. doi: 10.1038/41483.
6
Evaluation of rapid molecular methods for detection of clarithromycin resistance in Helicobacter pylori.用于检测幽门螺杆菌对克拉霉素耐药性的快速分子方法的评估
Eur J Clin Microbiol Infect Dis. 1997 Feb;16(2):162-4. doi: 10.1007/BF01709478.
7
Susceptibility of Helicobacter pylori isolates against agents commonly administered for eradication therapy and the efficacy of chemotherapy.
Microbiol Immunol. 1997;41(1):7-12. doi: 10.1111/j.1348-0421.1997.tb01166.x.
8
A PCR-oligonucleotide ligation assay to determine the prevalence of 23S rRNA gene mutations in clarithromycin-resistant Helicobacter pylori.一种用于测定克拉霉素耐药幽门螺杆菌中23S rRNA基因突变发生率的聚合酶链反应-寡核苷酸连接测定法。
Antimicrob Agents Chemother. 1997 Mar;41(3):712-4. doi: 10.1128/AAC.41.3.712.
9
Prevalence of primary Helicobacter pylori resistance to metronidazole and clarithromycin in The Netherlands.荷兰原发性幽门螺杆菌对甲硝唑和克拉霉素的耐药率
Eur J Clin Microbiol Infect Dis. 1996 Nov;15(11):861-4. doi: 10.1007/BF01691216.
10
Quantitative study of Helicobacter pylori in gastric mucus by competitive PCR using synthetic DNA fragments.使用合成DNA片段通过竞争性聚合酶链反应对胃黏液中幽门螺杆菌进行定量研究。
J Clin Microbiol. 1996 Oct;34(10):2421-5. doi: 10.1128/jcm.34.10.2421-2425.1996.

在无克拉霉素暴露史的患者中,同时存在23S rRNA基因有突变和无突变的幽门螺杆菌定植。

Simultaneous colonisation of Helicobacter pylori with and without mutations in the 23S rRNA gene in patients with no history of clarithromycin exposure.

作者信息

Matsuoka M, Yoshida Y, Hayakawa K, Fukuchi S, Sugano K

机构信息

Department of Gastroenterology, Mishuku Hospital, 5-33-12 Kamimeguro, Meguro-ku, Tokyo, Japan 153.

出版信息

Gut. 1999 Oct;45(4):503-7. doi: 10.1136/gut.45.4.503.

DOI:10.1136/gut.45.4.503
PMID:10486356
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1727681/
Abstract

BACKGROUND

It was recently reported that A to G transition mutations at positions 2143 and 2144 in the 23S rRNA gene are associated with clarithromycin resistance in Helicobacter pylori.

AIMS

To study the incidence and mechanism of development of clarithromycin resistance by analysing these mutations.

SUBJECTS

Eighty two H pylori positive patients who had an endoscopic examination and no history of treatment with macrolide antibiotics.

METHODS

Clarithromycin resistance was screened for by polymerase chain reaction-restriction fragment length polymorphism of the 23S rRNA gene coupled with antibiotic susceptibility testing. In clinical isolates with mutations or resistance, mutations in individual colonies were analysed by direct sequencing.

RESULTS

Of the 79 amplicons (DNA fragments amplified by polymerase chain reaction), Alw26I and MboII digestion disclosed the mutation in four (5%) and one (1%) respectively. However, the Alw26I cleavage was incomplete in two of the four amplicons, as was the MboII cleavage. Individual colony analysis of the isolates with incomplete cleavage patterns showed the presence of both wild type and mutated strains in the 23S rRNA genes.

CONCLUSIONS

Both clarithromycin sensitive and resistant strains colonised in some patients with no history of exposure to macrolides. The results suggest that resistant strains may not be formed but selected by clarithromycin administration.

摘要

背景

最近有报道称,23S rRNA基因中第2143和2144位的A到G转换突变与幽门螺杆菌对克拉霉素的耐药性有关。

目的

通过分析这些突变来研究克拉霉素耐药性的发生率和产生机制。

研究对象

82例幽门螺杆菌阳性患者,这些患者接受了内镜检查且无大环内酯类抗生素治疗史。

方法

通过23S rRNA基因的聚合酶链反应-限制性片段长度多态性结合抗生素敏感性试验来筛选克拉霉素耐药性。对于有突变或耐药的临床分离株,通过直接测序分析单个菌落中的突变情况。

结果

在79个扩增子(通过聚合酶链反应扩增的DNA片段)中,Alw26I和MboII酶切分别在4个(5%)和1个(1%)中检测到突变。然而,在4个扩增子中的2个中Alw26I酶切不完全,MboII酶切也是如此。对酶切模式不完全的分离株进行单个菌落分析,结果显示在23S rRNA基因中同时存在野生型和突变型菌株。

结论

在一些无大环内酯类药物接触史的患者中,同时存在克拉霉素敏感和耐药菌株。结果表明,耐药菌株可能不是由克拉霉素给药形成的,而是被其选择出来的。